Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that all patients in the ongoing Phase III study for the drug candidate AKP02G2 have been ...
Understanding fiber's role in nutrition reveals its potential in preventing chronic diseases, improving gut health, and reducing colorectal cancer risk.
In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at the Obesity Society Annual Meeting (ObesityWeek) 2024. For the presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback